Skip to main content

TFC Financial Management, Inc.

Position in NVO — Novo Nordisk A S

CIK 1827844 BOSTON, MA

Position in NVO

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$77,614
-$33,775 QoQ
Shares Held
1,619
-46.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,088
of 1,348 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

TFC Financial Management, Inc. holds $19,845,722 across 13 Drug Manufacturers - General names. NVO ranks #7 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 NVO
Novo Nordisk A S
This page
1,619 $77,614

All Filings in NVO

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $77,614 1,619
2026-03-31 $111,389 3,031
2025-12-31 $154,217 3,031
2025-09-30 $163,196 2,941
2025-06-30 $196,016 2,840
2025-03-31 $230,888 3,325
2024-12-31 $322,661 3,751
2024-09-30 $461,991 3,880
2024-06-30 $548,835 3,845
2024-03-31 $493,698 3,845
2023-12-31 $417,938 4,040
2023-09-30 $367,397 4,040
2023-06-30 $363,308 2,245
2023-03-31 $577,996 3,632
2022-12-31 $491,554 3,632
2022-09-30 $361,856 3,632
2022-06-30 $414,073 3,716
2022-03-31 $423,766 3,816
2021-12-31 $398,944 3,562
2021-09-30 $301,183 3,137
2021-06-30 $249,802 2,982
2021-03-31 $197,136 2,924
2020-12-31 $208,991 2,992
2020-09-30 $187,183 2,696